COVID-19-associated rhino-orbito-cerebral mucormycosis: a single center prospective study of 264 patients
Kim U, Perzia B, Kulkarni P, Rajiniganth M, Sundar B, Robin A, Shukla A, Maeng M. COVID-19-associated rhino-orbito-cerebral mucormycosis: a single center prospective study of 264 patients. Orbit 2024, 44: 24-33. PMID: 39051497, DOI: 10.1080/01676830.2024.2377249.Peer-Reviewed Original ResearchTranscutaneous retrobulbar amphotericin BRhino-orbital-cerebral mucormycosisRhino-orbitalCavernous sinusBiopsy-proven mucormycosisOutbreak of mucormycosisRetrobulbar amphotericin BNo light perceptionAssociated with high mortalityAssociated with increased mortalityEndoscopic sinus debridementPre-existing diabetesCerebral diseaseSymptomatic COVID-19Asymptomatic COVID-19Oral posaconazoleSinus debridementEye involvementWorse visionVision recoveryNew diabetesImmune dysregulationAmphotericin BClinical outcomesWeekly imaging
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply